|
Market Closed -
Other stock markets
|
After hours 20:00:00 | |||
| 99.12 USD | -5.08% |
|
100.10 | +0.99% |
| 08-05 | Health Care Up After Mixed Earnings -- Health Care Roundup | DJ |
| 08-05 | CVS, Eli Lilly Forge Partnership on Improved GLP-1 Access; Companies Top Second-Quarter Views | MT |
| Market Cap | 127B 110B 102B 94.14B 178B 12,054B 180B 1,203B 472B 6,031B 476B 466B 19,975B | P/E 2026 * |
15x | P/E 2027 * | 13.7x |
|---|---|---|---|---|---|
| Enterprise Value | 183B 158B 147B 136B 256B 17,357B 259B 1,732B 680B 8,684B 686B 670B 28,762B | EV / Sales 2026 * |
0.44x | EV / Sales 2027 * | 0.42x |
| Free-Float |
71.2% | Yield 2026 * |
2.68% | Yield 2027 * | 2.78% |
Last Transcript: CVS Health Corporation
| 1 day | +0.99% | ||
| 1 week | -6.42% | ||
| Current month | -5.08% | ||
| 1 month | -5.35% | ||
| 3 months | +22.84% | ||
| 6 months | +29.86% | ||
| Current year | +24.90% |
| 1 week | 93.5 |  | 105.77 |
| 1 month | 93.5 | | 110.68 |
| Current year | 69.51 | | 110.68 |
| 1 year | 62.55 | | 110.68 |
| 3 years | 43.56 | | 110.68 |
| 5 years | 43.56 | | 111.25 |
| 10 years | 43.56 | | 111.25 |
| Manager | Title | Age | Since |
|---|---|---|---|
J. Joyner
CEO | Chief Executive Officer | 62 | 2024-10-16 |
Brian Newman
DFI | Director of Finance/CFO | 57 | 2025-05-11 |
Ali Keshavarz
PSD | President | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
C. Brown
BRD | Director/Board Member | 74 | 2007-02-28 |
Anne Finucane
BRD | Director/Board Member | 73 | 2011-01-19 |
| Director/Board Member | 71 | 2015-03-04 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 5/14/26 | Free | Director | 1,737 | 0.0001% | ||
| 2/28/26 | Tax | Executive/Senior Manager | 7,886 | 0.0006% | ||
| 2/28/26 | Tax | Chief Executive Officer | 1,944 | 0.0002% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -5.08% | -6.42% | +56.29% | +35.99% | 127B | |
| +2.22% | +0.36% | +12.60% | +52.46% | 88.69B | |
| +5.16% | +4.78% | +12.57% | +66.31% | 30.34B | |
| +0.91% | +0.26% | +36.11% | +73.86% | 26.03B | |
| +0.25% | +1.27% | -7.81% | -15.85% | 22.32B | |
| +3.32% | +1.60% | +63.29% | +251.42% | 21.08B | |
| -17.24% | -21.69% | +34.28% | +73.41% | 12.03B | |
| -0.36% | -5.21% | -2.91% | -12.18% | 12.64B | |
| -1.03% | -5.16% | -16.01% | +83.24% | 11.05B | |
| +2.26% | +2.08% | +4.23% | +27.76% | 10.39B | |
| Average | -0.82% | -2.58% | +19.26% | +63.64% | 36.13B | |
| Weighted average by Cap. | +0.63% | -2.51% | +30.38% | +55.44% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 417B 361B 336B 309B 584B 39,624B 591B 3,954B 1,552B 19,826B 1,565B 1,531B 65,662B | 427B 370B 345B 317B 598B 40,586B 605B 4,050B 1,589B 20,307B 1,603B 1,568B 67,256B |
| Net income | 8.63B 7.48B 6.97B 6.41B 12.1B 821B 12.24B 81.9B 32.14B 411B 32.42B 31.71B 1,360B | 9.28B 8.04B 7.49B 6.89B 13.01B 883B 13.16B 88.07B 34.57B 442B 34.87B 34.1B 1,463B |
| Net Debt | 55.76B 48.3B 45.02B 41.41B 78.17B 5,302B 79.05B 529B 208B 2,653B 209B 205B 8,787B | 52.15B 45.17B 42.1B 38.72B 73.11B 4,959B 73.92B 495B 194B 2,481B 196B 192B 8,217B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-08-05 | US$99.12 | -5.08% | 18,514,644 |
| 26-08-04 | US$104.42 | -0.90% | 7,229,227 |
| 26-08-03 | US$105.37 | +0.90% | 5,377,252 |
| 26-07-31 | US$104.43 | -0.75% | 7,081,286 |
| 26-07-30 | US$105.22 | -0.66% | 7,738,249 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- CVS Stock
Select your edition
All financial news and data tailored to specific country editions
